Cargando…

Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review

Background: Fractional exhaled nitric oxide (FeNO) is a biomarker of airway inflammation associated with airway hyper-responsiveness and type-2 inflammation. Its role in the management of severe asthmatic patients undergoing biologic treatment, as well as FeNO dynamics during biologic treatment, is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pianigiani, Tommaso, Alderighi, Lorenzo, Meocci, Martina, Messina, Maddalena, Perea, Beatrice, Luzzi, Simona, Bergantini, Laura, D’Alessandro, Miriana, Refini, Rosa Metella, Bargagli, Elena, Cameli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952501/ https://www.ncbi.nlm.nih.gov/pubmed/36829959 http://dx.doi.org/10.3390/antiox12020400

Ejemplares similares

Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
por: Cameli, Paolo, et al.
Publicado: (2020)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
por: Bergantini, Laura, et al.
Publicado: (2021)

Metabolic Dysregulation in Idiopathic Pulmonary Fibrosis
por: Bargagli, Elena, et al.
Publicado: (2020)

Adaptive immune system in pulmonary sarcoidosis—Comparison of peripheral and alveolar biomarkers
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
por: Cameli, Paolo, et al.
Publicado: (2020)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
por: Cameli, Paolo, et al.
Publicado: (2022)

Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae
por: Bergantini, Laura, et al.
Publicado: (2023)

Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility
por: Cameli, Paolo, et al.
Publicado: (2020)

The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis
por: Refini, Rosa Metella, et al.
Publicado: (2020)

Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study
por: Cameli, Paolo, et al.
Publicado: (2021)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis
por: Bergantini, Laura, et al.
Publicado: (2022)

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena
por: Vietri, Lucia, et al.
Publicado: (2020)

Measurements of fractional exhaled nitric oxide in pediatric asthma
por: Hahn, Youn-Soo
Publicado: (2013)

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
por: Bennett, David, et al.
Publicado: (2020)

Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014)

The Fraction Exhaled Nitric Oxide as a Biomarker of Asthma Control
por: de Abreu, Fernanda Cruvinel, et al.
Publicado: (2019)

Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013)

Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023)

Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
por: Bergantini, Laura, et al.
Publicado: (2022)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

Fraction of exhaled nitric oxide measurements in the diagnoses of asthma in elderly patients
por: Godinho Netto, Antonio Carlos Maneira, et al.
Publicado: (2016)

Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019)

Annual Fractional Exhaled Nitric Oxide Measurements and Exacerbations in Severe Asthma
por: Abe, Yuki, et al.
Publicado: (2020)

Evaluation of Fractional Exhaled Nitric Oxide in Pediatric Asthma and Allergic Rhinitis
por: Jang, Yoon Young, et al.
Publicado: (2020)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
por: Bergantini, Laura, et al.
Publicado: (2021)

KL-6 in ANCA-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach
por: Conticini, Edoardo, et al.
Publicado: (2022)

Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review
por: Essat, Munira, et al.
Publicado: (2016)

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Importance of fractional exhaled nitric oxide in the differentiation of asthma–COPD overlap syndrome, asthma, and COPD
por: Chen, Feng-jia, et al.
Publicado: (2016)

Utility of serological biomarker’ panels for diagnostic accuracy of interstitial lung diseases
por: Bergantini, Laura, et al.
Publicado: (2020)

Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort
por: Bal, Christina, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapy
por: Landi, Claudia, et al.
Publicado: (2020)

Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II
por: d’Alessandro, Miriana, et al.
Publicado: (2022)

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kh30shqilqrmphdiv6orqtekan